Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up.
暂无分享,去创建一个
Yu-jing Zhang | Z. Xia | Liang Wang | Yue Lu | Wei-da Wang | Jin Xiang
[1] Jun Zhu,et al. A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type , 2013, Journal of Hematology & Oncology.
[2] Y. Xia,et al. First‐line combination of gemcitabine, oxaliplatin, and L‐asparaginase (GELOX) followed by involved‐field radiation therapy for patients with stage IE/IIE extranodal natural killer/T‐cell lymphoma , 2013, Cancer.
[3] Hui-Qiang Huang,et al. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients , 2012, International Journal of Hematology.
[4] R. Suzuki,et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Q. Cai,et al. Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience , 2011, Leukemia & lymphoma.
[6] P. Gaulard,et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. , 2011, Blood.
[7] K. Ohshima,et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Jiade J Lu,et al. Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma , 2009, Clinical Cancer Research.
[9] Biyun Wang,et al. Immunohistochemical expression and clinical significance of P‐glycoprotein in previously untreated extranodal NK/T‐cell lymphoma, nasal type , 2008, American journal of hematology.
[10] D. Weisenburger,et al. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] İ. Zindancı,et al. Extranodal NK/T cell lymphoma, nasal type. , 2008, European journal of dermatology : EJD.
[12] Jiyan Liu,et al. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. , 2008, International journal of radiation oncology, biology, physics.
[13] C. Copie-Bergman,et al. Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] S. Schuster,et al. Selective apoptosis of natural killer‐cell tumours by l‐asparaginase , 2005, British journal of haematology.
[15] J. Roh,et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Bates,et al. P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines , 1991, International journal of cancer.